The effects of single administration of Lactobacillus plantarum No. 14 (LP14) on human body temperature and factors related to sympathetic nerves were measured in a randomized, double-blind, cross-over study. LP14 significantly increased chest temperature (P < 0.05). The maximum difference in temperature between LP14 and placebo was 0.24 ± 0.24℃. Systolic blood pressure increased significantly, and arousal scores tended to increase in the LP14 group. The results of the Uchida-Kraepelin test indicated that LP14 elevated task performance. Our results demonstrated that LP14 induced thermogenesis in humans. We also examined the activity of the sympathetic nerves (SNA) innervating brown adipose tissue (BAT) in rats. The activity of BAT-SNA was significantly enhanced in the LP14 group. As LP14 changed factors associated with sympathetic nerves in humans and elevated sympathetic nerve activity in rats, sympathetic nerve activation appears to participate in thermogenesis elicited by LP14.
Introduction
Lactobacillus plantarum No. 14 (LP14) was isolated from pickled shallots, and was deposited as FERM P-11550 in the International Patent Organism Depository (Ibaraki, Japan) by Momoya Co. Ltd. (Tokyo, Japan). The LP14 strain decreases body fat percentage with antiallergic effects (Nagata et al., 2010; Nagata et al., 2008) , and is the first reported lactic acid bacterium to decrease body fat in humans. LP14 administered to mice fed a high-fat diet reduces the mean size of adipocytes and white adipose tissue weight (Takemura et al., 2010) . Reported mechanisms of body fat loss induced by other bacterial strains (through conjugated linoleic acids and inhibition of dietary fat absorption) are probably not involved in the action of LP14.
We reported that LP14 induces gene expression of interleukin (IL)-1β (Nagata et al., 2010) , which induces fever when systemically administered or directly delivered to the brain (Blatteis and Sehic, 1998; Dinarello, 1984; Gwosdow et al., 1990) . Two routes are known to send intra-intestinal information to the brain including hormonal information in the blood and afferent neural signals. Immune signals such as IL-1β induced prostaglandin (PG) E 2 in brain endothelial cells (Nakamura et al., 2002) , from which it is released into the brain parenchyma, where it activates PGE receptors on neurons and then triggers the neural circuitry for fever induction. Metabolic heat production increases when sympathetic nerves innervating brown adipose tissue are activated, whereas blood vessels contract to minimize heat loss when sympathetic nerves innervating vascular smooth muscle are activated (Nagashima et al., 2000) . Skeletal muscles create shivering thermogenesis when motor nerves are activated. The effects are similar when endogenous cytokines are released in response to lipopolysaccharide (LPS) derived from gram-negative bacteria. We speculated that body fat decreases because LP14 induces thermogenesis through sympathetic nerve activation. We thus measured the effects of a singleadministration of LP14 on human body temperature. The sympathetic autonomic system is involved in blood pressure, pulse rate, arousal and body temperature through catecholamine release from the adrenal medulla and sympathetic nerve endings (Christensen and Jensen, 1994; Duncko et al., 2007) . We therefore measured these factors in this study. Furthermore, as arousal is involved in task performance (Dlusskaia et al., 2002) , we considered that such task performance would be improved by elevating arousal induced by LP14. We thus evaluated task performance hourly using the Uchida-Kraepelin (U-K) test. We also investigated Therm, Tokyo, Japan) with a precision of 0.01℃. Blood pressure and pulse rate were measured every 20 min using an upper arm automatic blood pressure monitor (HEM-7115; Omron Healthcare, Kyoto, Japan). The U-K test (Kashiwagi et al., 1985) , the Stanford Sleepiness Scale (SSS; Hoddes et al., 1973) and the Stress Arousal Checklist (SACL; Mackay et al., 1978) were applied every hour. The U-K test is a serial addition test that requires individuals to perform calculations as fast and as accurately as possible. Although the U-K test is usually performed in repeated cycles of 15 min of work and 5 min of rest, our study subjects were tested during only one 5-min work period with no rest periods. In the SSS questionnaire, one of seven statements is selected to best describe the current state of alertness of the subjects and the SACL is a mood adjective checklist consisting of 17 items about stress and 13 about arousal.
The subjects were also asked to describe awareness of a difference in body temperature between days one and two. Subject blinding was confirmed by having the subjects indicate which sample they believed they had received (test sample, placebo, or unknown) after measurements on day two.
Animals The ANBAS Corporation (Osaka, Japan) performed BAT-SNA. Animal care and handling procedures were approved by the Institutional Animal Care and Use Committee of the ANBAS Corporation in accordance with the guidelines for animal experiments issued by the Science Council of Japan on June 1, 2006. Nine-week-old male SD rats (n = 6) weighing about 300 g were housed individually in a room at 24℃ and illuminated for 12 h (8:00 − 20:00) per day. Rats were acclimated to the environment for at least one week before the experiment and were divided into two groups. Food (MF, Oriental Yeast, Tokyo, Japan) and water were freely available.
BAT-SNA was determined by the methods of Tanida et al. (2005) . Rats fasted for 3 h and were anesthetized with urethane (1 g/kg, intraperitoneally) before surgery. Laparotomy was performed, and then the distal ends of the sympathetic nerves innervating the interscapular BAT were exposed, ligated and subsequently connected with a pair of silver wire electrodes. Body temperature was maintained at 35.0 ± 0.5℃ using a heat pad and a rectal thermistor. After a stabilization period of 30 to 60 min, signals from the electrodes were collected, amplified, filtered and monitored on an oscilloscope. Nerve activity was analyzed by converting the raw data into standard pulses using a window discriminator. Baseline values of BAT-SNA were collected for 5 min before delivering an intragastric injection of LP14 (9.7 × 10 8 CFU/0.5 mL water) or water (0.5 mL). Lyophilized LP14 that was prepared as described above was administered in water. The BAT-SNA the effects of an intragastric injection of LP14 on the activity of sympathetic nerves innervating brown adipose tissue (BAT-SNA) in rats.
Materials and Methods
Subjects and study design We enrolled two men and 19 women (mean age, 21.5 ± 3.9 years; range, 18 − 31 years). All subjects were non-smokers and were not taking medications at the time of enrollment.
This randomized, double-blind, cross-over study proceeded between the end of July and the beginning of October 2010. At least one day elapsed between the individual experimental runs. Investigation of the effects of LP14 and placebo was completed within seven days and did not take place during menstruation.
Subjects consumed their normal supper at the usual time and retired at the same time on the day before the study. They also awakened at the same time in the morning and wore the same clothes on each day of the investigation. Subjects refrained from vigorous exercise for 24 h and fasted (consuming only water) for at least 10 h before experiments, which started at 8:30 a.m. Thermosensors were placed on the chest and the dorsum of the right foot, and subjects then rested for 30 min while seated in an air-conditioned room at 24.9 ± 0.7℃ and 66.2 ± 6.4% relative humidity. Baseline data were collected, and subjects swallowed one capsule with 100 mL of water (25℃). The investigation was stopped after three hours. The study proceeded in accordance with the Declaration of Helsinki, and all procedures were approved by the Ethics Committee of Kagawa Nutrition University. Written informed consent was obtained from all subjects before enrolling in the study.
Preparation of active and placebo samples LP14 was pre-cultured and then cultured in MRS medium at a concentration of 1% at 30℃ for 24 h. The culture medium was then pasteurized at 100℃ for 20 min. After cooling, ethanol was added to a final concentration of 70%, and the mixture was stored at 4℃ for 48 h. Precipitates were suspended in distilled water, precipitated again with a 70% volume of ethanol and separated by centrifugation at 13,000 × g for 20 min at 4℃. Precipitates were resuspended and lyophilized. Cellulose capsules were filled with 0.2 g (1.6 × 10 11 CFU) of lyophilized LP14 that comprised 91.8% and 8.2% (w/w) material of bacterial and medium origins, respectively. Placebo capsules prepared by the same method without inoculation respectively comprised 8.2% and 91.8% (w/w) material of medium origin and branched dextrin to adjust the weight.
Measurements We measured skin temperature every five seconds at the chest and dorsum of the right foot using ITP010-22 thermistors and an N542R data logger (Nikkoso-perature tended to be higher in response to LP14 than to the placebo from 45 to 90 min (P < 0.10) and was significantly higher from 135 to 165 min (135 and 150 min, P = 0.022; 165 min, P < 0.001). The maximum difference between chest temperature after ingesting LP14 and placebo was 0.24 ± 0.24℃ at 165 min. Foot temperature decreased and did not significantly differ between the two groups ( Fig. 1b) .
Blood pressure and pulse rate Systolic blood pressure peaked at 2 and 2.7 h after ingesting placebo and LP14, respectively, and significantly differed between the two groups at 2.7 h (P = 0.017, Fig. 2a ). Pulse rate decreased in both groups, but to a lesser extent in the LP14 group at 2.7 h (P = 0.068, Fig. 2b) .
U-K test The total number of answers increased and decreased at 1 h after ingesting LP14 and placebo, respectively and significantly differed (P = 0.028, Fig. 3a ). The number of errors gradually decreased and increased after ingesting LP14 and placebo, respectively and significantly differed at 2 h after ingestion (P = 0.032, Fig. 3b ).
SSS and SACL Sleepiness or stress scores did not significantly differ between the groups (data not shown). Arousal scores tended to differ at 2 h after ingestion (P = 0.080, Fig.  4) . The response to each arousal item was analyzed. Scores were significantly higher in the LP14 than in the placebo group for "not tired" (P = 0.022 at 2 h after ingestion) and "not alert" (P = 0.007 at 3 h after ingestion) and tended to be higher for "vigorous" (P = 0.067 at 2 h after ingestion) and "not sleepy" (P = 0.098 at 3 h after ingestion).
Post-study questionnaire The two groups did not significantly differ with respect to altered body temperature (data not shown). One subject correctly identified the ingested samples, two incorrectly identified the samples, and 18 could was recorded for 90 min after the injection.
Statistical analysis The order effects of all parameters in the human study were examined using analysis of variance (ANOVA) according to a cross-over design. Only the total number of answers on the U-K test differed significantly (P = 0.037). Subjects seemed relatively unfamiliar with the test, although they had three minutes of practice immediately before the experiment. Therefore, we only analyzed the total number of answers on the second day using an unpaired ttest. Other parameters including the number of errors on the U-K test were analyzed by combining the data obtained on the first two days using a paired t-test or the Wilcoxon t-test. Data from the questionnaire regarding altered body temperature were assessed by chi-squared test. Deviations from baseline calculated for all data are expressed as means ± SD.
Group responses of BAT-SNA were compared using ANOVA with repeated measures and ratios (%) of deviation from baseline values are expressed as means ± SEM.
All statistical tests were two-sided. Statistical significance was set at P < 0.05. Data were statistically analyzed using SPSS 6.1 software (SPSS, Chicago, IL, USA) and ystat2006 (Igakutosho-Shuppan, Ltd., Tokyo, Japan).
Results
Body temperature Subjects whose body temperature differed by more than 1.0℃ between LP14 and placebo on ingestion were excluded from temperature analysis. Chest and foot data were each excluded from two subjects. The average increase in chest temperature was 0.10 ± 0.32℃ and 0.24 ± 0.32℃ in the placebo and LP14 groups, respectively (Fig. 1a ). The average increase in chest temperature differed significantly between the two groups (P = 0.023). Chest tem-Thermogenesis by L. plantarum in Japanese Subjects Data are expressed as means ± SD of ((Experimental period) -(Time point zero)) in the placebo (○) and LP14 (•) groups. Groups were compared using unpaired and paired t-test for total number of answers (placebo, n = 8; LP14, n = 13), and number of errors (n = 21), respectively. *P < 0.05. Data are expressed as means ± SD of ((Experimental period) -(Time point zero)) in the placebo (○) and LP14 (•) groups. Values between groups were compared using Wilcoxon t-test (n = 21). thermogenesis (Cannon and Nedergaard, 2004; Lowell and Spiegelman, 2000) . The mechanisms of BAT thermogenesis principally depend on the activation of uncoupling protein 1 (UCP1), which uncouples oxidative phosphorylation in mitochondria to dissipate the electrochemical gradient as heat. BAT persists throughout life in rodents but disappears soon after birth in large mammals (Lean and James, 1986) . Significant roles of BAT in the regulation of energy expenditure and adiposity in small rodents have been established but have remained controversial in humans. However, extensive BAT has recently been confirmed in adult humans by the detection of UCP1 (Garruti et al., 1992; Oberkofler et al., 1997) . Saito et al. (2009) found using positron emission tomography (PET) and X-ray computed tomography (CT) that the uptake of 2-[ 18 F]fluoro-2-deoxyglucose (FDG) into adipose tissues in the supraclavicular and paraspinal regions of healthy volunteers was substantial at 19℃. Histological examination confirmed the presence of BAT in these regions. The activation of BAT might be involved in the control of body temperature in adult humans. The activity of UCP1 is controlled by the sympathetic nerves that innervate BAT, mainly through β-adrenergic mechanisms. The activator of sympathetic nerves, β3 adrenergic receptor, also induces lipolysis in BAT (Robidoux et al., 2004) , and the generated fatty acids are used as substrates for UCP1 thermogenesis (Inokuma et al., 2006) . β3 agonists promote lipolysis in white adipocytes, activate UCP1, change free fatty acids into heat and decrease body fat (Sasaki et al., 1998) . Injected Lactobacillus paracasei ST11 also elevates sympathetic nerve activity, blood pressure and temperature in the rat abdominal cavity and BAT, reduces abdominal fat (Tanida et al., 2008) . L. paracasei ST11 affects the hypothalamic suprachiasmatic nucleus (SCN) of the brain and causes sympathetic elevation. LP14 ingestion elevated the values of factor associated with sympathetic nerves in humans and enhanced BAT-SNA in rats. We plan to investigate whether LP14 alters sympathetic nerve activity in humans. Blatteis (1976) originally suggested that BAT is involved in thermogenesis associated with fever, as an endotoxin-induced, β-blocker-sensitive increase in BAT temperature was demonstrated in guinea pigs. Later studies found that injected IL-1β/LPS increases guanosine diphosphate (GDP) binding to BAT mitochondria, which is a marker of UCP1 activity (Dascombe et al., 1989; Jepson et al., 1988; Rothwell, 1989) . Blood flow in BAT increases in rats injected with IL-1β/LPS (Dascombe et al., 1989) . We speculated that body fat decreases because LP14 induces thermogenesis through IL-1β gene expression and sympathetic nerve activation. The results of our study supported the hypothesis. The ability of LP14 to decrease body fat might relate to its immunostimula-not distinguish between them. Therefore, effective blinding was confirmed.
BAT-SNA in rats Figure 5 shows changes compared with 0 min BAT-SNA values after administering LP14 and water. Water slightly enhanced BAT-SNA after 40 min, with a peak of 124.2% at 75 min. LP14 gradually enhanced the BAT-SNA with a peak of 152.9% at 75 min after administration. The difference in BAT-SNA between the two groups was statistically significant (time, P = 0.101; sample, P < 0.001; time × sample, P = 0.999).
Discussion
Chest temperature increased significantly after ingestion of LP14, as compared with placebo. Lactic acid bacteria have not been reported to elevate body temperature in humans. The body temperature of rats increased after feeding with lactic acid bacteria (Tanida et al., 2008) , and the body temperature of humans increases by 1.8 − 3.4℃ from baseline after the administration of E. coli LPS, and this is accompanied by chills, headache and nausea (Soop et al., 2004; Fijen et al., 2001) . The maximum increase in chest temperature in the present study after LP14 and placebo ingestion was 0.46℃ and 0.22℃, respectively, from baseline without subjective symptoms. The increase in body temperature caused by LP14 was moderate.
Foot temperature fell by 4℃ in both groups. The temperature of the air-conditioned room in which the experiment was conducted, was 24.9 ± 0.7℃. Because peripheral temperature is easily influenced by ambient temperature, foot temperature decreased sharply in the present study. LP14 did not affect foot temperature.
Blood pressure increased and pulse rates decreased with circadian rhythms in the placebo group. LP14 further increased systolic blood pressure and tended to suppress pulse rate. When sympathetic nerves innervating vascular smooth muscle are activated, the blood vessels constrict to minimize heat loss, which increases blood pressure (Nagashima et al., 2000) . LP14 increased blood pressure, but did not suppress heat loss.
The placebo group became significantly fatigued when compared with the LP14 group. Arousal scores tended to be higher in the LP14 than in the placebo group. The total number of answers and the number of errors in the U-K test significantly differed between the two groups. LP14 ingestion improved task performance. Changes in arousal score seemed to be involved in task performance even though the changes did not significantly differ.
We examined the effects of intragastric injection of LP14 on BAT-SNA in rats. BAT is involved in metabolic heat production and plays a significant role in cold-and diet-induced tory capacity. This notion requires further study.
LP14 produces large amounts of exopolysacccharides (EPS). Most lactic acid bacteria and bifidobacteria produce one or two EPS with a different molar mass, polarity and pH (Salazar et al., 2009) . A few strains produce three or more EPS. LP14 produces two neutral and two acidic EPS (Hashiguchi et al., 2011) . Acidic EPS produced by lactic acid bacteria have immunomodulatory and protective effects. Stimulating mouse splenocytes with the acidic EPS of Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 increases IFN-γ production, and orally administered acidic EPS augments natural killer cell activity (Makino et al., 2006) . The acidic EPS of Lactococcus lactis ssp. cremoris KVS20 induces IFN-γ and IL-1α production in macrophages (Kitazawa et al., 1996) . However, both acidic and neutral EPS produced by LP14 exert immunostimulatory effects in porcine Peyer's patch cells and mesenteric lymph node cells (Hashiguchi et al., 2011) . The EPS of LP14 might participate in thermogenesis through an immunostimulatory mechanism. On the other hand, LP14 induces gene expression of interleukin (IL)-1β (Nagata et al., 2010) , so LP14 cellular factors might be involved in thermogenesis.
LP14 induced thermogenesis in humans. Blood pressure was significantly higher and task performance was significantly better in the LP14 than in the placebo group, and the arousal score tended to be higher. LP14 enhanced BAT-SNA in rats. As LP14 changed factors associated with sympathetic nerve activity in humans and elevated sympathetic nerve activity in rats, sympathetic nerve activation might participate in thermogenesis elicited by LP14.
